GSA Capital Partners LLP lowered its stake in shares of Envista Holdings Co. (NYSE:NVST – Free Report) by 71.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 19,564 shares of the company’s stock after selling 48,946 shares during the quarter. GSA Capital Partners LLP’s holdings in Envista were worth $387,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the stock. GAMMA Investing LLC lifted its stake in Envista by 69.8% in the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock worth $35,000 after purchasing an additional 726 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in Envista by 2.3% during the 2nd quarter. Victory Capital Management Inc. now owns 36,021 shares of the company’s stock valued at $599,000 after acquiring an additional 800 shares during the period. Blue Trust Inc. grew its position in Envista by 69.7% during the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares during the last quarter. Finally, Arizona State Retirement System increased its stake in Envista by 2.1% in the 2nd quarter. Arizona State Retirement System now owns 48,111 shares of the company’s stock worth $800,000 after purchasing an additional 1,006 shares during the period.
Analyst Ratings Changes
Several research firms have recently issued reports on NVST. Stifel Nicolaus upped their target price on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Bank of America cut their target price on Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, August 8th. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and upped their price objective for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a report on Thursday, October 31st. Finally, Wells Fargo & Company started coverage on shares of Envista in a research note on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 target price for the company. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.71.
Envista Price Performance
NYSE NVST opened at $21.39 on Friday. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Envista Holdings Co. has a 12 month low of $15.15 and a 12 month high of $25.64. The stock has a market cap of $3.68 billion, a price-to-earnings ratio of -2.75, a PEG ratio of 2.82 and a beta of 1.30. The company’s 50 day moving average is $19.44 and its two-hundred day moving average is $18.16.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.09 by $0.03. The firm had revenue of $601.00 million for the quarter, compared to the consensus estimate of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The company’s revenue was down 4.8% on a year-over-year basis. During the same period last year, the firm earned $0.43 EPS. As a group, research analysts anticipate that Envista Holdings Co. will post 0.72 earnings per share for the current year.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
- Five stocks we like better than Envista
- 5 discounted opportunities for dividend growth investors
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- 3 Healthcare Dividend Stocks to Buy
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Consumer Staples Stocks, Explained
- TJX Companies Stock Poised to Hit a New High This Year
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.